Stay informed about the latest diabetes news and research, including medical discoveries, treatment developments, clinical studies, technology and emerging health insights.
Brazil’s swift legislative actions on tirzepatide highlight how emerging markets are increasingly challenging pharmaceutical patents, risking sudden legal exposures under TRIPS flexibilities. The move signals a potential shift in global drug pricing and access strategies. Brazil’s fast-track vote on tirzepatide…
Scientists at Harvard Medical School have discovered a gene, ALDH3B2, that acts as a brake on insulin production in pancreatic cells. Its suppression could enable the reprogramming of duct cells into insulin-producing beta-like cells, paving the way for new diabetes…
A new study suggests that sustained control of blood sugar and blood pressure over a year provides more accurate prediction of kidney complications in people with type 2 diabetes than single clinic measurements. A year’s worth of blood sugar and…
Emerging evidence urges a broader approach to obesity treatment, emphasising muscle preservation and metabolic health alongside weight reduction, as specialists challenge traditional metrics of success. A growing body of 2026 evidence is pushing obesity specialists to judge the new generation…
Eli Lilly’s diabetes medication Mounjaro has received FDA approval for a new indication to reduce cardiovascular risk in high-risk adults with type 2 diabetes, marking a significant advancement in its clinical use and competitive positioning. Eli Lilly has won a…
India’s growing GLP-1 medication sector is experiencing a seismic shift as affordable generics challenge premium brands like Mounjaro and Ozempic, transforming the landscape of diabetes and obesity treatments. India’s drug market has entered a new phase in which GLP-1 medicines,…
As the 150th anniversary of John Macleod’s birth approaches, memorial efforts in Scotland and Canada highlight his essential contributions to insulin’s development, shifting longstanding disputes to civic remembrance. A century and a half after John James Rickard Macleod was born…
High blood sugar readings in the morning may be caused by the body’s natural hormonal surge, not just diet or medication, prompting a need for personalised monitoring and management strategies. For many people with diabetes, an unexpected high reading first…
Emerging advice stresses that daily diabetic foot routines are primarily about damage limitation, with a focus on inspection, proper drying, and cautious moisture management to prevent serious complications. The strongest point to emerge from the latest guidance is that daily…
Brazil’s diabetes drug market sees a swift increase in competition as EMS’s Yluméc gains regulatory approval, marking a significant shift following the patent expiry of Ozempic and Wegovy in the country. Brazil’s fast-opening semaglutide market widened again on 31 August…
GSK’s mRNA seasonal flu candidate progresses to late-stage trials, while new cardiovascular and cancer research highlight emerging trends and strategies at the latest DDW round-up ahead of the Drug Discovery Innovators & Investors Digital Forum. DDW’s latest weekly round-up points…
New research suggests that fibre-rich leafy and cruciferous vegetables like broccoli and kale may support insulin sensitivity and glucose control, highlighting the importance of a varied vegetable-rich diet in managing diabetes risk. Green vegetables may do more than round out…
